These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6955028)

  • 1. Tumor cell differentiation modulates susceptibility to natural killer cells.
    Werkmeister J; Helfand SL; Haliotis T; Rubin P; Pross H; Roder J
    Cell Immunol; 1982 May; 69(1):122-7. PubMed ID: 6955028
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cells and their targets: impact of differentiation on target cell susceptibility.
    Gidlund M; Nilsson K; Tötterman T; Wigzell H
    Haematol Blood Transfus; 1983; 28():466-9. PubMed ID: 6574961
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of natural killer susceptibility by indole alkaloid tumor promoter dihydroteleocidin B.
    Kabelitz D
    Cell Immunol; 1984 Aug; 87(1):304-8. PubMed ID: 6378393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell activity in depressive illness: preliminary report.
    Kronfol Z; Nair M; Goodson J; Goel K; Haskett R; Schwartz S
    Biol Psychiatry; 1989 Nov; 26(7):753-6. PubMed ID: 2804197
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cells kill tumour cells at a given stage of differentiation.
    Gidlund M; Orn A; Pattengale PK; Jansson M; Wigzell H; Nilsson K
    Nature; 1981 Aug; 292(5826):848-50. PubMed ID: 7266653
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lectin-inducible cell cytotoxicity and the production of the cytotoxic factor of natural killer cells during immobilization stress in mice].
    Sukhikh GT; Malaĭtsev VV; Bogdanova IM
    Biull Eksp Biol Med; 1985 Jul; 100(7):51-3. PubMed ID: 3860263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of leukoregulin enhancement of target cell susceptibility to NK cell mediated cytotoxicity in humans.
    Ransom JH; Evans CH; McCabe RP; Hanna MG
    Adv Exp Med Biol; 1985; 184():281-7. PubMed ID: 3862336
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of natural cytotoxicity by alloantibodies. V. The mechanism of a selective augmenting effect of anti-H-2 antisera on the natural killer activity of mouse spleen cells.
    Saxena RK; Saxena QB; Adler WH
    Cell Immunol; 1981 Nov; 65(1):115-30. PubMed ID: 6797740
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A function for human T200 in natural killer cytolysis.
    Sparrow RL; McKenzie IF
    Transplantation; 1983 Aug; 36(2):166-71. PubMed ID: 6603688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer (NK) activity of normal human peripheral blood lymphocytes against erythroleukemic cell line K 562.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):115-26. PubMed ID: 6946049
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of erythroid differentiation in K562 cells and natural killer cell-mediated lysis: distinct effects at the level of recognition and lysis in relation to target cell proliferation.
    Hagner G
    Immunobiology; 1984 Oct; 167(4):389-97. PubMed ID: 6595216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced susceptibility to natural killer cell lysis of hamster tumours exhibiting high levels of spontaneous metastasis.
    Teale DM; Rees RC; Clark A; Walker JR; Potter CW
    Cancer Lett; 1983 Jun; 19(2):221-9. PubMed ID: 6309364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the susceptibility of K562 to natural cytotoxicity: evidence for clonal variation in differentiation-induced changes of lytic sensitivity.
    Kimber I; Moore M; Harrison CJ
    Int J Cancer; 1984 May; 33(5):693-700. PubMed ID: 6202648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
    J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine in vitro antigenic modification of tumor cells: effect on susceptibility to natural cell-mediated cytotoxicity.
    Langweiler M; Weinhold KJ; Matthews TJ; Bolognesi DP
    J Natl Cancer Inst; 1985 Mar; 74(3):699-704. PubMed ID: 2983140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG-induced natural killer cells: immunotherapeutic implications.
    Henney CS; Tracey DE; Wolfe SA
    Isr J Med Sci; 1978 Jan; 14(1):75-88. PubMed ID: 632083
    [No Abstract]   [Full Text] [Related]  

  • 20. An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells.
    Raska K; Gallimore PH
    Virology; 1982 Nov; 123(1):8-18. PubMed ID: 7147716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.